2-(3-cyclopropyloxy-5-fluoro-4-propan-2-ylphenyl)triazole;(3,3-difluoroazetidin-1-yl)-(3-fluoro-4-propan-2-ylphenyl)methanone;2-(3,5-difluoro-4-propan-2-ylphenyl)-1,4,5-trimethylimidazole;2-[3-(3,3-difluoropyrrolidin-1-yl)-5-fluoro-4-propan-2-ylphenyl]-1-methylimidazole;2-(3-ethoxy-5-fluoro-4-propan-2-ylphenyl)-1-methylimidazole;4-[3-fluoro-5-(1-methylimidazol-2-yl)-2-propan-2-ylphenyl]morpholine;2-(2-fluoro-3-propan-2-ylphenyl)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine;2-(2-fluoro-3-propan-2-ylphenyl)-6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazine;2-(2-fluoro-3-propan-2-ylphenyl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole;2-(2-fluoro-3-propan-2-ylphenyl)-8,8-dimethyl-5,6-dihydroimidazo[2,1-c][1,4]oxazine;3-(2-fluoro-3-propan-2-ylphenyl)-1,5-dimethyl-1,2,4-triazole;3-(3-fluoro-4-propan-2-ylphenyl)-1-methylpyrazole;3-(3-fluoro-4-propan-2-ylphenyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine
C195H231F18N29O7 — CID 160505551
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(3-cyclopropyloxy-5-fluoro-4-propan-2-ylphenyl)triazole;(3,3-difluoroazetidin-1-yl)-(3-fluoro-4-propan-2-ylphenyl)methanone;2-(3,5-difluoro-4-propan-2-ylphenyl)-1,4,5-trimethylimidazole;2-[3-(3,3-difluoropyrrolidin-1-yl)-5-fluoro-4-propan-2-ylphenyl]-1-methylimidazole;2-(3-ethoxy-5-fluoro-4-propan-2-ylphenyl)-1-methylimidazole;4-[3-fluoro-5-(1-methylimidazol-2-yl)-2-propan-2-ylphenyl]morpholine;2-(2-fluoro-3-propan-2-ylphenyl)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine;2-(2-fluoro-3-propan-2-ylphenyl)-6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazine;2-(2-fluoro-3-propan-2-ylphenyl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole;2-(2-fluoro-3-propan-2-ylphenyl)-8,8-dimethyl-5,6-dihydroimidazo[2,1-c][1,4]oxazine;3-(2-fluoro-3-propan-2-ylphenyl)-1,5-dimethyl-1,2,4-triazole;3-(3-fluoro-4-propan-2-ylphenyl)-1-methylpyrazole;3-(3-fluoro-4-propan-2-ylphenyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine
2-(3-cyclopropyloxy-5-fluoro-4-propan-2-ylphenyl)triazole;(3,3-difluoroazetidin-1-yl)-(3-fluoro-4-propan-2-ylphenyl)methanone;2-(3,5-difluoro-4-propan-2-ylphenyl)-1,4,5-trimethylimidazole;2-[3-(3,3-difluoropyrrolidin-1-yl)-5-fluoro-4-propan-2-ylphenyl]-1-methylimidazole;2-(3-ethoxy-5-fluoro-4-propan-2-ylphenyl)-1-methylimidazole;4-[3-fluoro-5-(1-methylimidazol-2-yl)-2-propan-2-ylphenyl]morpholine;2-(2-fluoro-3-propan-2-ylphenyl)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine;2-(2-fluoro-3-propan-2-ylphenyl)-6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazine;2-(2-fluoro-3-propan-2-ylphenyl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole;2-(2-fluoro-3-propan-2-ylphenyl)-8,8-dimethyl-5,6-dihydroimidazo[2,1-c][1,4]oxazine;3-(2-fluoro-3-propan-2-ylphenyl)-1,5-dimethyl-1,2,4-triazole;3-(3-fluoro-4-propan-2-ylphenyl)-1-methylpyrazole;3-(3-fluoro-4-propan-2-ylphenyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine (PubChem CID 160505551) has the molecular formula C195H231F18N29O7 and a molecular weight of 3435.15 g/mol. Its IUPAC name is 2-(3-cyclopropyloxy-5-fluoro-4-propan-2-ylphenyl)triazole;(3,3-difluoroazetidin-1-yl)-(3-fluoro-4-propan-2-ylphenyl)methanone;2-(3,5-difluoro-4-propan-2-ylphenyl)-1,4,5-trimethylimidazole;2-[3-(3,3-difluoropyrrolidin-1-yl)-5-fluoro-4-propan-2-ylphenyl]-1-methylimidazole;2-(3-ethoxy-5-fluoro-4-propan-2-ylphenyl)-1-methylimidazole;4-[3-fluoro-5-(1-methylimidazol-2-yl)-2-propan-2-ylphenyl]morpholine;2-(2-fluoro-3-propan-2-ylphenyl)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine;2-(2-fluoro-3-propan-2-ylphenyl)-6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazine;2-(2-fluoro-3-propan-2-ylphenyl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole;2-(2-fluoro-3-propan-2-ylphenyl)-8,8-dimethyl-5,6-dihydroimidazo[2,1-c][1,4]oxazine;3-(2-fluoro-3-propan-2-ylphenyl)-1,5-dimethyl-1,2,4-triazole;3-(3-fluoro-4-propan-2-ylphenyl)-1-methylpyrazole;3-(3-fluoro-4-propan-2-ylphenyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine.
Molecular Properties
| Compound Name | 2-(3-cyclopropyloxy-5-fluoro-4-propan-2-ylphenyl)triazole;(3,3-difluoroazetidin-1-yl)-(3-fluoro-4-propan-2-ylphenyl)methanone;2-(3,5-difluoro-4-propan-2-ylphenyl)-1,4,5-trimethylimidazole;2-[3-(3,3-difluoropyrrolidin-1-yl)-5-fluoro-4-propan-2-ylphenyl]-1-methylimidazole;2-(3-ethoxy-5-fluoro-4-propan-2-ylphenyl)-1-methylimidazole;4-[3-fluoro-5-(1-methylimidazol-2-yl)-2-propan-2-ylphenyl]morpholine;2-(2-fluoro-3-propan-2-ylphenyl)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine;2-(2-fluoro-3-propan-2-ylphenyl)-6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazine;2-(2-fluoro-3-propan-2-ylphenyl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole;2-(2-fluoro-3-propan-2-ylphenyl)-8,8-dimethyl-5,6-dihydroimidazo[2,1-c][1,4]oxazine;3-(2-fluoro-3-propan-2-ylphenyl)-1,5-dimethyl-1,2,4-triazole;3-(3-fluoro-4-propan-2-ylphenyl)-1-methylpyrazole;3-(3-fluoro-4-propan-2-ylphenyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine |
|---|---|
| PubChem CID | 160505551 |
| Molecular Formula | C195H231F18N29O7 |
| Molecular Weight | 3435.15 g/mol |
| Exact Mass | 3432.83 |
| IUPAC Name | 2-(3-cyclopropyloxy-5-fluoro-4-propan-2-ylphenyl)triazole;(3,3-difluoroazetidin-1-yl)-(3-fluoro-4-propan-2-ylphenyl)methanone;2-(3,5-difluoro-4-propan-2-ylphenyl)-1,4,5-trimethylimidazole;2-[3-(3,3-difluoropyrrolidin-1-yl)-5-fluoro-4-propan-2-ylphenyl]-1-methylimidazole;2-(3-ethoxy-5-fluoro-4-propan-2-ylphenyl)-1-methylimidazole;4-[3-fluoro-5-(1-methylimidazol-2-yl)-2-propan-2-ylphenyl]morpholine;2-(2-fluoro-3-propan-2-ylphenyl)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine;2-(2-fluoro-3-propan-2-ylphenyl)-6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazine;2-(2-fluoro-3-propan-2-ylphenyl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole;2-(2-fluoro-3-propan-2-ylphenyl)-8,8-dimethyl-5,6-dihydroimidazo[2,1-c][1,4]oxazine;3-(2-fluoro-3-propan-2-ylphenyl)-1,5-dimethyl-1,2,4-triazole;3-(3-fluoro-4-propan-2-ylphenyl)-1-methylpyrazole;3-(3-fluoro-4-propan-2-ylphenyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine |
| SMILES | CC(C)c1c(F)cc(-c2nccn2C)cc1N1CCC(F)(F)C1.CC(C)c1c(F)cc(-c2nccn2C)cc1N1CCOCC1.CC(C)c1c(F)cc(-n2nccn2)cc1OC1CC1.CC(C)c1ccc(-c2ccn(C)n2)cc1F.CC(C)c1ccc(-c2ncc3n2CCCC3)cc1F.CC(C)c1ccc(C(=O)N2CC(F)(F)C2)cc1F.CC(C)c1cccc(-c2cn3c(n2)C(C)(C)OCC3)c1F.CC(C)c1cccc(-c2cn3c(n2)CCC3)c1F.CC(C)c1cccc(-c2cn3c(n2)COCC3)c1F.CC(C)c1cccc(-c2cn3c(n2)OCCC3)c1F.CCOc1cc(-c2nccn2C)cc(F)c1C(C)C.Cc1nc(-c2cc(F)c(C(C)C)c(F)c2)n(C)c1C.Cc1nc(-c2cccc(C(C)C)c2F)nn1C |
| InChI | InChI=1S/C17H20F3N3.C17H22FN3O.C17H21FN2O.C16H19FN2.C15H18F2N2.2C15H17FN2O.C15H19FN2O.C15H17FN2.C14H16FN3O.C13H14F3NO.C13H16FN3.C13H15FN2/c1-11(2)15-13(18)8-12(16-21-5-7-22(16)3)9-14(15)23-6-4-17(19,20)10-23;1-12(2)16-14(18)10-13(17-19-4-5-20(17)3)11-15(16)21-6-8-22-9-7-21;1-11(2)12-6-5-7-13(15(12)18)14-10-20-8-9-21-17(3,4)16(20)19-14;1-11(2)14-7-6-12(9-15(14)17)16-18-10-13-5-3-4-8-19(13)16;1-8(2)14-12(16)6-11(7-13(14)17)15-18-9(3)10(4)19(15)5;1-10(2)11-5-3-6-12(14(11)16)13-9-18-7-4-8-19-15(18)17-13;1-10(2)11-4-3-5-12(15(11)16)13-8-18-6-7-19-9-14(18)17-13;1-5-19-13-9-11(15-17-6-7-18(15)4)8-12(16)14(13)10(2)3;1-10(2)11-5-3-6-12(15(11)16)13-9-18-8-4-7-14(18)17-13;1-9(2)14-12(15)7-10(18-16-5-6-17-18)8-13(14)19-11-3-4-11;1-8(2)10-4-3-9(5-11(10)14)12(18)17-6-13(15,16)7-17;1-8(2)10-6-5-7-11(12(10)14)13-15-9(3)17(4)16-13;1-9(2)11-5-4-10(8-12(11)14)13-6-7-16(3)15-13/h5,7-9,11H,4,6,10H2,1-3H3;4-5,10-12H,6-9H2,1-3H3;5-7,10-11H,8-9H2,1-4H3;6-7,9-11H,3-5,8H2,1-2H3;6-8H,1-5H3;3,5-6,9-10H,4,7-8H2,1-2H3;3-5,8,10H,6-7,9H2,1-2H3;6-10H,5H2,1-4H3;3,5-6,9-10H,4,7-8H2,1-2H3;5-9,11H,3-4H2,1-2H3;3-5,8H,6-7H2,1-2H3;5-8H,1-4H3;4-9H,1-3H3 |
| InChIKey | QSISOIVBUKEJSX-UHFFFAOYSA-N |
| XLogP | 46.67 |
| TPSA | 321.79 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 35 |
| Rotatable Bonds | 32 |
| Heavy Atoms | 249 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3435.15 |
| LogP ≤ 5 | 46.67 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 35 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 160505551 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.